Recursion Pharmaceuticals, Inc.
Ticker: RXRX
| Insider | Title |
|---|---|
| Blake Borgeson | Director |
| Capital Management Uk Llp Mic | 10% or greater ownership |
| Capital Partners (public) (us) Im, Llc Mic | 10% or greater ownership |
| Capital Partners (public) Parallel Cayman, Lp Mic | 10% or greater ownership |
| Christopher Gibson | Chief Executive Officer, Director |
| Co-invest Opportunities, L.p. Lux | 10% or greater ownership |
| Co-invest Partners, Llc Lux | 10% or greater ownership |
| David J Mauro | Chief Medical Officer |
| Dean Y Li | Director |
| Diversified Global Holding Pjsc Mamoura | 10% or greater ownership |
| Investment Co Pjsc Mubadala | 10% or greater ownership |
| Josh Wolfe | 10% or greater ownership |
| Michael Secora | Chief Financial Officer |
| Najat Khan | Chief RD Commercial Officer, Director |
| Peter Hebert | 10% or greater ownership |
| R. Martin Chavez | Director |
| Ramona Doyle | Chief Medical Officer |
| Robert Hershberg | Director |
| Shafique Virani | Chief Business Officer |
| Terry-ann Burrell | Director |
| Tina Marriott | President and COO |
| Venture Partners Iv, Llc Lux | 10% or greater ownership |
| Ventures Iv, L.p. Lux | 10% or greater ownership |
| Zachary Bogue | Director, 10% or greater ownership |
| Zavain Dar | Director |